To spur innovation, a manufacturer would have to come to the table with essential human data, data that the drug will work on humans, will be safe and effective on humans.
Gene Green: “To spur innovation, a manufacturer would have to come to the table with essential human data, data that the drug will…”
On the recordSeptember 12, 2017
Source
congress.govEditor's note · Context
Gene Green discusses the need for human data to promote innovation in drug manufacturing.
Share
More from Gene Green
Sep 25, 2018
Neither these bills nor the Committee's other efforts have gone far enough to address many of the underlying challenges facing this sector.
Dec 10, 2018
I would like to thank Dr. Rucker for testifying today on the Office of National Coordinator's work to implement the 21st Century Cures Act.
Sep 26, 2018
These numbers are troubling as we are because even more acute when you look at the existing racial, socioeconomic, and geographic disparities.
Sep 26, 2018
The Centers for Disease Control and Prevention reports that more than 700 women in the United States die each year due to complications related to pregnancy and childbirth.





